Organ-on-a-chip (OOC) devices, simulating organ physiology on small chips, find applications in drug screening and disease modeling.
The interest in microfluidics in the BioTech industry stems from the need for lab-on-a-chip (LOC) devices. These miniaturized labs enable affordable, swift testing of infectious diseases, paving the way for point-of-care diagnostics. Paper-based microfluidics for diagnostics and environmental monitoring are being developed by startups. Organ-on-a-chip (OOC) devices, simulating organ physiology on small chips, find applications in drug screening and disease modeling.